# Filing Detail

Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material:
SEC Accession No. 0001104659-21-134440
Filing Date
2021-11-04
Accepted
2021-11-04 16:45:22
Documents
3

Document Format Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
1 | DEFA14A | tm2130904-3_defa14a.htm | DEFA14A | 21107
2 | GRAPHIC | tm2130904d3-px_vote14c.jpg | GRAPHIC | 538229
3 | GRAPHIC | tm2130904d3-px_vote24c.jpg | GRAPHIC | 387334
| Complete submission text file | 0001104659-21-134440.txt |  | 1295918

Mailing Address 100 HIGH STREET 28TH FLOOR BOSTON MA 02110
Business Address 100 HIGH STREET 28TH FLOOR BOSTON MA 02110 617-349-1971
Astria Therapeutics, Inc. (Filer) CIK: 0001454789 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEFA14A | Act: 34 | File No.: 001-37467 | Film No.: 211380612
SIC: 2834 Pharmaceutical Preparations